Homology Medicines Announces FDA Fast Track Designation for HMI-102 Gene Therapy Development Candidate Genetics Investing
Genetic Technologies Completes Two Genetic Risk Tests for Colorectal and Breast Cancer Genetics Investing
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial Biotech Investing